Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

VEOZAH is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause. VEOZAH is not a ...

The Food and Drug Administration (FDA) just approved a brand-new, once-a-day pill to help treat hot flashes without the use of hormones. The drug, called elinzanetant—brand name Lynkuet—was created by ...

The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause ...

(CNN) — The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

The Food and Drug Administration has approved a new pill for menopausal women to treat hot flashes and night sweats. Drug manufacturer Bayer created the first-ever FDA-approved non-hormonal medication ...

Oct 24 (Reuters) - The U.S. Food and Drug Administration has approved Bayer's (BAYGn.DE), opens new tab drug to ease hot flashes in menopausal women, the German company said on Friday, a welcome ...

Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. The Food and Drug Administration approved the drug — also known by ...

Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and ...